Now showing items 4861-4880 of 17688

    • Ruhl, J. B.; Posner, Stephen M.; Ricketts, Taylor H. (PLoS One, 2019-08-01)
      Many scientific researchers aspire to engage policy in their writing, but translating scientific research and findings into policy discussion often requires an understanding of the institutional complexities of legal and ...
    • Sigmon, Casey Thornburgh (2017-04-04)
      Department: Religion
      Homileticians have felt the pressure and the apathy of emerging postmodern cultures about the church and its preaching. From Clyde Reid to Fred Craddock, John McClure to David Lose, Lucy Rose to Sarah Travis—the hunch has ...
    • Sasson, Jack M. (Neukirchener Verlagshaus, 1976)
      "The main purpose of this paper, offered in tribute to the doyen of Sumerian belles-lettres, is to collect the Mari evidence on the figure of the E/i. Its conclusions do not mean to dispute the third definition of the CAD ...
    • McGrath, Allison Reilly (2013-11-25)
      Department: Sociology
      The advent of the Internet has led to a surge in hate group mobilization, providing affiliates of organized racism with a cost-efficient way to distribute information about white supremacy. Hate groups have grown in strength ...
    • Greenlee, Joshua D.; King, Michael R. (Biomicrofluidics, 2020-01)
      The majority of all cancers metastasize initially through the lymphatic system. Despite this, the mechanisms of lymphogenous metastasis remain poorly understood and understudied compared to hematogenous metastasis. Over ...
    • Xu, Zhou (2011-04-16)
      Department: Chemical Engineering
      DNA microarrays have become an increasingly important tool for genomic investigations. This work is directed toward establishing methods and surface architectures that allow the monitoring of DNA hybridization and ...
    • Lopez Cavestany, Maria; 0000-0001-5358-3746 (2023-07-14)
      Department: Biomedical Engineering
      In the United States, cancer deaths have dropped by 27% in the last 20 years. Although there has been great progress, effective treatment options for metastatic colorectal cancer (CRC) are still limited, and stage 4 cancers ...
    • Lopez Cavestany, Maria; 0000-0001-5358-3746 (2023-07-14)
      Department: Biomedical Engineering
      In the United States, cancer deaths have dropped by 27% in the last 20 years. Although there has been great progress, effective treatment options for metastatic colorectal cancer (CRC) are still limited, and stage 4 cancers ...
    • Hapach, Lauren A.; Mosier, Jenna A.; Wang, Wenjun; Reinhart-King, Cynthia A. (NPJ Precision Oncology, 2019-08-21)
      While considerable progress has been made in studying genetic and cellular aspects of metastasis with in vitro cell culture and in vivo animal models, the driving mechanisms of each step of metastasis are still relatively ...
    • Balotin, Kylie; 0000-0001-9641-9145 (2022-05-16)
      Department: Biomedical Engineering
      Neurodegenerative diseases are increasing in prevalence as the population of the United States ages. There are currently no cures or effective treatments for many of these diseases, likely in part due to the lack of ...
    • Jiang, Liwei (Vanderbilt University. Dept. of Physics and Astronomy, 2011-04)
      The study of living specimens is essential to the understanding of organismal behavior. Unfortunately, a major difficulty in the study of live organisms is that many move in and out of the field of view or focal plane ...
    • Wandishin, Clayton Michael; 0000-0002-6779-7451 (2022-03-30)
      Department: Other
      Small cell lung cancer (SCLC) is a highly aggressive disease, characterized by a signature “tumor recurrence” during treatment, wherein after initial favorable response, tumors re-establish themselves and no longer respond ...
    • Lee, Sue Hyun (2016-04-15)
      Department: Biomedical Engineering
      Tissue engineering promises to solve the ever-increasing organ donor shortage, as well as to provide personalized and customized cures for numerous life-threatening diseases and organ/tissue failures. While significant ...
    • Sevy, Alexander Mario (2018-09-21)
      Department: Chemical and Physical Biology
      Antibodies are a key component of the human immune response to infectious disease. The best anti-viral antibody response is one that is potent and broad, covering a large number of the many diverse viral variants. ...
    • Share, Keith Edward (2018-06-26)
      Department: Interdisciplinary Materials Science
      Renewable energy from wind and solar are no longer solely motivated by their environmental benefits but are now also economically competitive. Batteries are a key component in both the renewable grid infrastructure and ...
    • Garland, Kyle M.; 0000-0003-0722-4245 (2021-12-01)
      Department: Chemical Engineering
      The development of cancer occurs when immunosuppression inhibits the naturally occurring process through which the immune system recognizes and eliminates cancer cells (i.e. the cancer-immunity-cycle). While clinically ...
    • Hu, Shuren (2016-12-21)
      Department: Physics
      Engineering light-matter interaction at the nanoscale has the promise to enable technological advances in a wide range of technological applications, including biomolecular sensing, communication, quantum optics, displays, ...
    • Baljon, Jessalyn Jane; 0000-0002-6524-3869 (2023-03-13)
      Department: Biomedical Engineering
      Immune checkpoint blockade (ICB) has revolutionized cancer treatment and has led to complete and durable responses, but only for a minority of patients. Resistance to ICB can largely be attributed to insufficient number ...
    • Knight, Frances Clare; 0000-0001-8892-7262 (2020-06-12)
      Department: Biomedical Engineering
      Tissue-resident memory T cells (TRM) patrol non-lymphoid organs and provide superior protection against pathogens that commonly infect mucosal and barrier tissues, such as the lungs, intestine, liver, and skin. At these ...
    • Carson, Carcia; 0000-0003-3424-695X (2022-03-25)
      Department: Biomedical Engineering
      Traditional approaches to cancer vaccines elicit weak CD8+ T cell responses and have largely failed to meet clinical expectations. This is in part due to inefficient antigen cross-presentation, inappropriate selection of ...